Britain’s medicines regulator said four prescription-only Zantac medicines, including a syrup, an injection and tablets in 150 and 300 milligram doses, would be recalled.
Over-the-counter Zantac products are produced by a different company.
The decision is “precautionary” as health regulators in the U.S. and U.K. continue to review the safety of products with ranitidine, a drug that reduces stomach acid.
More articles on pharmacy:
Telemedicine startup to open first brick-and-mortar pharmacy
Top 10 pharmacy stories in September
Novant Health to open health clinics inside Walgreens
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
